Renal Safety after More Than a Decade of Deferasirox Use in Patients with Transfusional Hemosiderosis

被引:2
|
作者
Origa, Raffaella [1 ]
Piga, Antonio [2 ]
Tartaglione, Immacolata [3 ]
Della Corte, Giuseppina [4 ]
El-Ali, Ali [5 ]
Han, Jackie [6 ]
Castiglioni, Chiara [7 ]
Forni, Gian Luca [8 ]
机构
[1] Univ Cagliari, Osped Pediat Microcitem A Cao, Cagliari, Italy
[2] Univ Turin, S Luigi Gonzaga Hosp, Ctr Microcitemie, Turin, Italy
[3] Univ Naples 2, Naples, Italy
[4] Univ Milan, Ca Granda Fdn IRCCS, Milan, Italy
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] Novartis Farma SpA, Origgio, Italy
[8] Galliera Hosp, Genoa, Italy
关键词
D O I
10.1182/blood.V128.22.2466.2466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2466
引用
收藏
页数:5
相关论文
共 50 条
  • [1] RENAL SAFETY AFTER MORE THAN A DECADE OF DEFERASIROX USE IN PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS
    Origa, Raffaella
    Piga, Antonio
    Tartaglione, Immacolata
    Della Corte, Giuseppina
    Bruederle, Andreas
    Han, Jackie
    Castiglioni, Chiara
    Forni, Gian Luca
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E347 - E347
  • [2] Iron chelation efficiency of deferasirox (Exjade®, ICL670) in patients with transfusional hemosiderosis
    Porter, J
    Borgna-Pignatti, C
    Baccarani, M
    Saviano, A
    Abish, S
    Malizia, R
    Nick, H
    Opitz, H
    Rabault, B
    Gathmann, I
    Marks, P
    [J]. BLOOD, 2005, 106 (11) : 755A - 756A
  • [3] INTERNATIONAL SENTINEL SITE SURVEILLANCE OF PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS TREATED WITH DEFERASIROX IN ACTUAL PRACTICE SETTING
    El-Beshlawy, A.
    Inusa, B.
    Beneitez, D.
    Xicoy, B.
    Duran Nieto, M. Soledad
    Vorog, A.
    Azmon, A.
    Gilotti, G.
    Elalfy, M.
    [J]. HAEMATOLOGICA, 2016, 101 : 609 - 610
  • [4] EXPERIENCE OF THE USE OF DEFERASIROX IN PAEDIATRIC PATIENTS WITH TRANSFUSIONAL DEPENDENCY
    Faci Cristina, Martinez
    Sanjuan Laura, Murillo
    Cebrian Flor, Yus
    Maria Angeles, Montanes Gracia
    Flores Maria Del Valle, Recasens
    Iturrate Carmen, Rodriguez-Vigil
    [J]. HAEMATOLOGICA, 2016, 101 : 265 - 265
  • [5] International sentinel site surveillance of patients with transfusional hemosiderosis treated with deferasirox in actual practice setting
    Ei-Beshlawy, Amal
    Inusa, Baba
    Beneitez Pastor, David
    Xicoy, Blanca
    Duran Nieto, Maria Soledada
    Bruederle, Andreas
    Azmon, Amin
    Gilotti, Geralyn
    Elalfy, Mohsen
    [J]. HEMATOLOGY, 2019, 24 (01) : 238 - 246
  • [6] LONG-TERM IRON CHELATION THERAPY WITH DEFERASIROX IN PEDIATRIC PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS (ENTRUST)
    Vichinsky, Elliott
    El-Beshlawy, Amal
    Alzoebie, Azzam
    Kamdem, Annie
    Koussa, Suzanne
    Chotsampancharoen, Thirachit
    Bruederle, Andreas
    Han, Jackie
    Elalfy, Mohsen
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E444 - E444
  • [7] The Safety, Tolerability and Efficacy of Deferasirox in Older Patients with Transfusional Dependent Anemia
    Arboscello, Eleonora
    Del Corso, Lisette
    Giacchello, Jacopo Agnelli
    Balleari, Enrico
    Bellodi, Andrea
    Di Grazia, Carmen
    Dominietto, Alida
    Favorini, Serena
    Ghiso, Anna
    Giovannini, Martina
    Molinari, Elisa
    Salvetti, Chiara
    Sicbaldi, Vera
    Strada, Paolo
    Ubezio, Gianluca
    Van Lint, Maria Teresa
    Vignolo, Luana
    Ghio, Riccardo
    [J]. BLOOD, 2014, 124 (21)
  • [8] LONG-TERM SAFETY AND EFFICACY OF DEFERASIROX IN PEDIATRIC PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS: RESULTS FROM A 5-YEAR OBSERVATIONAL STUDY (ENTRUST)
    Vichinsky, E.
    El Beshlawy, A.
    Alzoebie, A.
    Kamdem, A.
    Koussa, S.
    Chotsampancharoen, T.
    Bruederle, A.
    Gilotti, G.
    Han, J.
    Elalfy, M.
    [J]. HAEMATOLOGICA, 2016, 101 : 612 - 612
  • [9] SIMILAR TRENDS IN RENAL FUNCTION AS MEASURED BY SERUM CREATININE DURING LONG-TERM IRON CHELATION TREATMENT WITH OR WITHOUT DEFERASIROX IN PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS
    Origa, R.
    Piga, A.
    Tartagliona, I.
    Della Corte, G.
    Bruederle, A.
    Han, J.
    Castiglioni, C.
    [J]. HAEMATOLOGICA, 2017, 102 : 88 - 88
  • [10] Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST)
    Vichinsky, Elliott
    El-Beshlawy, Amal
    Al Zoebie, Azzam
    Kamdem, Annie
    Koussa, Suzanne
    Chotsampancharoen, Thirachit
    Bruederle, Andreas
    Gilotti, Geralyn
    Han, Jackie
    Elalfy, Mohsen
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (09)